Need of orthogonal approaches in neurological disease modeling in mouse

Linda Bossini1,2, Alessandro Sessa1

  • 1Neuroepigenetics Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Insights

Recent failures in neurological disease clinical trials highlight issues with current animal models. This review explores innovative strategies and orthogonal approaches to improve the reliability and translatability of neurological disease modeling.

Area of Science:

  • Neurology
  • Translational Medicine
  • Biomedical Research

Background:

  • Advancements in modeling neurological diseases have yielded innovative strategies for deeper insights and treatments.
  • However, increasing clinical trial failures raise concerns about the reliability and translatability of current disease models.
  • This highlights a critical need to reassess and improve existing animal models for neurological conditions.

Purpose of the Study:

  • To briefly review recent approaches in neurological disease modeling.
  • To identify intriguing strategies that can inspire improvements in current animal models.
  • To advocate for an orthogonal approach in studying human neurological diseases.

Main Methods:

  • Mini-review of recent literature on neurological disease modeling.
  • Focus on innovative strategies and their application.
  • Analysis of approaches for enhancing model translatability.

Main Results:

  • Identified several intriguing strategies in recent neurological disease modeling.
  • Highlighted the potential of an orthogonal approach to improve disease study.
  • Emphasized the need for enhanced reliability and translatability in animal models.

Conclusions:

  • Current neurological disease models face challenges with clinical trial translatability.
  • Innovative strategies and orthogonal approaches offer promising avenues for improvement.
  • Further research into refined modeling techniques is crucial for advancing neurological disease treatment.

Related Concept Videos